David Baker Selected Research

CFM6104

1/2014

Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Baker Research Topics

Disease

77	Multiple Sclerosis 01/2022 - 01/2002
29	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2019 - 01/2002
19	Neoplasms (Cancer) 01/2021 - 07/2006
16	Infections 01/2022 - 02/2004
15	Human Influenza (Influenza) 01/2021 - 05/2011
13	Inflammation (Inflammations) 01/2022 - 08/2005
11	Alzheimer Disease (Alzheimer's Disease) 10/2016 - 06/2011
10	COVID-19 08/2022 - 07/2020
10	Demyelinating Diseases (Demyelinating Disease) 08/2021 - 04/2002
8	Disease Progression 10/2019 - 04/2003
6	Autoimmune Diseases (Autoimmune Disease) 10/2018 - 08/2006
6	Neuroinflammatory Diseases 03/2016 - 05/2003
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2008
5	Optic Neuritis (Retrobulbar Neuritis) 12/2017 - 08/2012
4	HIV Infections (HIV Infection) 01/2021 - 11/2011
4	Malaria 10/2020 - 01/2008
4	Pain (Aches) 11/2019 - 03/2002
4	Hypothermia 01/2014 - 05/2003
3	Necrosis 08/2021 - 07/2008
3	Communicable Diseases (Infectious Diseases) 07/2021 - 03/2014
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2017 - 03/2014
3	Cognitive Dysfunction 10/2016 - 09/2015
3	Atrophy 10/2016 - 09/2003
3	Acquired Immunodeficiency Syndrome (AIDS) 03/2016 - 07/2004
3	Muscle Spasticity (Spastic) 09/2013 - 03/2002
2	Anthrax 12/2021 - 09/2011
2	Bacterial Infections (Bacterial Infection) 12/2021 - 09/2011
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2021 - 01/2021
2	Arthritis (Polyarthritis) 08/2021 - 03/2006
2	Infertility (Sterility) 01/2021 - 02/2014
2	Reinfection 12/2020 - 01/2020
2	Weight Gain 01/2020 - 07/2017
2	Coinfection 01/2020 - 04/2016
2	Lymphopenia (Lymphocytopenia) 01/2019 - 05/2018
2	Nervous System Diseases (Neurological Disorders) 12/2017 - 01/2006
2	Celiac Disease (Celiac Sprue) 10/2015 - 12/2012
2	Poisoning 07/2014 - 01/2006

Drug/Important Bio-Agent (IBA)

42	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2002
20	CannabinoidsIBA 01/2022 - 03/2002
16	AntibodiesIBA 11/2021 - 04/2002
15	Pharmaceutical PreparationsIBA 01/2022 - 04/2006
14	Biomarkers (Surrogate Marker)IBA 10/2021 - 11/2010
12	Cladribine FDA LinkGeneric 01/2022 - 12/2015
11	Amyloid (Amyloid Fibrils)IBA 01/2021 - 04/2007
11	Hemagglutinins (Hemagglutinin)IBA 01/2020 - 05/2011
11	Peptides (Polypeptides)IBA 01/2019 - 01/2002
10	Alemtuzumab (Campath)FDA Link 01/2022 - 03/2004
9	Monoclonal AntibodiesIBA 01/2022 - 05/2012
9	AntigensIBA 11/2021 - 01/2002
8	VaccinesIBA 08/2022 - 01/2014
7	CytokinesIBA 01/2022 - 02/2005
7	EpitopesIBA 10/2020 - 01/2002
6	Antiviral Agents (Antivirals)IBA 07/2021 - 03/2003
5	Fingolimod Hydrochloride (FTY720)FDA Link 08/2022 - 07/2011
5	EnzymesIBA 12/2021 - 12/2012
5	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 05/2003
5	EndocannabinoidsIBA 01/2015 - 03/2002
5	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2014 - 07/2005
5	Cannabinoid Receptors (Cannabinoid Receptor)IBA 08/2009 - 03/2002
4	LigandsIBA 01/2021 - 10/2005
4	Biological ProductsIBA 01/2021 - 09/2014
4	Voltage-Gated Sodium ChannelsIBA 06/2015 - 09/2003
4	anandamide (arachidonylethanolamide)IBA 01/2006 - 03/2002
3	ocrelizumabIBA 01/2022 - 02/2017
3	Neutralizing AntibodiesIBA 11/2021 - 03/2014
3	InterferonsIBA 02/2017 - 11/2010
3	LipidsIBA 01/2017 - 05/2009
3	LipopolysaccharidesIBA 06/2014 - 03/2006
3	Glutamic Acid (Glutamate)FDA Link 09/2011 - 07/2008
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2005 - 01/2003
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 11/2018
2	COVID-19 VaccinesIBA 01/2022 - 01/2021
2	Retinaldehyde (Retinal)IBA 01/2022 - 02/2005
2	Capsules (Microcapsules)IBA 12/2021 - 09/2011
2	16S Ribosomal RNAIBA 10/2021 - 01/2021
2	Immunoglobulins (Immunoglobulin)IBA 08/2021 - 10/2019
2	Glycoproteins (Glycoprotein)IBA 01/2020 - 01/2002
2	Raltegravir Potassium FDA Link 01/2020 - 11/2011
2	Oligoclonal BandsIBA 10/2019 - 10/2018
2	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2019 - 01/2019
2	Myelin-Oligodendrocyte GlycoproteinIBA 01/2019 - 12/2013
2	Immunoglobulin G (IgG)IBA 11/2018 - 04/2002
2	TabletsIBA 10/2018 - 07/2017
2	DisulfidesIBA 01/2018 - 01/2016
2	Carrier Proteins (Binding Protein)IBA 11/2017 - 02/2016
2	Interferon beta-1a FDA Link 07/2017 - 01/2017
2	Natalizumab (Tysabri)FDA Link 02/2017 - 09/2014
2	RNA (Ribonucleic Acid)IBA 01/2016 - 11/2011
2	Peptide Hydrolases (Proteases)FDA Link 10/2015 - 12/2012
2	Glutens (Glutelin)IBA 10/2015 - 12/2012
2	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2015 - 01/2012
2	CuprizoneIBA 01/2015 - 01/2012
2	Neurofilament ProteinsIBA 03/2014 - 09/2013
2	EndonucleasesIBA 02/2014 - 05/2011
2	Sodium Channels (Sodium Channel)IBA 01/2014 - 09/2003

Therapy/Procedure

34	Therapeutics 08/2022 - 03/2003
8	Immunotherapy 01/2021 - 06/2005
4	Drug Therapy (Chemotherapy) 06/2019 - 11/2004
3	Injections 11/2021 - 12/2017
2	Ambulatory Care (Outpatient Care) 02/2015 - 09/2005